These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

863 related items for PubMed ID: 9846649

  • 21. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
    Okayama M, Mullol J, Baraniuk JN, Hausfeld JN, Feldman B, Merida M, Shelhamer JH, Kaliner MA.
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
    [Abstract] [Full Text] [Related]

  • 22. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 23. Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells.
    Hirota K, Hashimoto Y, Lambert DG.
    Anesth Analg; 2002 Dec; 95(6):1607-10, table of contents. PubMed ID: 12456425
    [Abstract] [Full Text] [Related]

  • 24. Muscarinic M1 and M3 receptors in rat striatum: a binding study.
    de la Vega MT, Nuñez A, Arias-Montaño JA.
    Arch Med Res; 1997 Dec; 28(4):493-7. PubMed ID: 9428572
    [Abstract] [Full Text] [Related]

  • 25. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 26. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
    Wall SJ, Yasuda RP, Li M, Wolfe BB.
    Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243
    [Abstract] [Full Text] [Related]

  • 27. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW.
    J Med Chem; 1998 Jun 04; 41(12):2047-55. PubMed ID: 9622546
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
    Olianas MC, Maullu C, Adem A, Mulugeta E, Karlsson E, Onali P.
    Br J Pharmacol; 2000 Oct 04; 131(3):447-52. PubMed ID: 11015294
    [Abstract] [Full Text] [Related]

  • 29. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
    Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, Wolfe BB.
    Mol Pharmacol; 1993 Feb 04; 43(2):149-57. PubMed ID: 8429821
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
    Hirose H, Aoki I, Kimura T, Fujikawa T, Numazawa T, Sasaki K, Sato A, Hasegawa T, Nishikibe M, Mitsuya M, Ohtake N, Mase T, Noguchi K.
    J Pharmacol Exp Ther; 2001 May 04; 297(2):790-7. PubMed ID: 11303071
    [Abstract] [Full Text] [Related]

  • 31. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
    Watson N, Daniels DV, Ford AP, Eglen RM, Hegde SS.
    Br J Pharmacol; 1999 May 04; 127(2):590-6. PubMed ID: 10385263
    [Abstract] [Full Text] [Related]

  • 32. Identification and characterization of m1 selective muscarinic receptor antagonists1.
    Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ.
    J Med Chem; 1999 Feb 11; 42(3):356-63. PubMed ID: 9986705
    [Abstract] [Full Text] [Related]

  • 33. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.
    Max SI, Liang JS, Valentine HH, Potter LT.
    J Pharmacol Exp Ther; 1993 Oct 11; 267(1):480-5. PubMed ID: 8229778
    [Abstract] [Full Text] [Related]

  • 34. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
    Witt-Enderby PA, Dubocovich ML.
    Mol Pharmacol; 1996 Jul 11; 50(1):166-74. PubMed ID: 8700109
    [Abstract] [Full Text] [Related]

  • 35. Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
    Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR.
    J Pharmacol Exp Ther; 1991 Feb 11; 256(2):727-33. PubMed ID: 1994002
    [Abstract] [Full Text] [Related]

  • 36. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 11; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 37. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec 11; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 38. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
    Jooste E, Klafter F, Hirshman CA, Emala CW.
    Anesthesiology; 2003 Apr 11; 98(4):906-11. PubMed ID: 12657852
    [Abstract] [Full Text] [Related]

  • 39. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC, Challiss RA, Nahorski SR.
    Br J Pharmacol; 2001 Feb 11; 132(4):950-8. PubMed ID: 11181437
    [Abstract] [Full Text] [Related]

  • 40. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
    Wylie PG, Challiss RA, Blank JL.
    Biochem J; 1999 Mar 15; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.